Expanding CTA to more stroke patients improves outcomes

Adopting a “CTA-for-All” policy helped radiologists detect large vessel occlusion (LVO) and improved outcomes for patients with acute ischemic stroke, according to a recent study published in Stroke

Currently, CT angiography (CTA) is only ordered for patients who arrive at the hospital within six hours of last known well (last known time a patient was without symptoms), with a National Institutes of Health Stroke Scale (NIHSS) score of six or greater. CTA-for-All, however, expands imaging—including non-contrast CT— to patients who present within 24 hours of last known well, without considering their NIHSS score.

After comparing outcomes between stroke patients admitted to the hospital one year before and one year after implementing the new policy, the researchers reported shorter times between emergency department arrival and CTA. Lead author Stephan A. Mayer, MD, and colleagues at Henry Ford Hospital in Detroit also detected more instances of LVO and reported better outcomes.

“These findings suggest that a uniform CTA-for-All imaging policy for stroke patients presenting within 24 hours is feasible and safe, improves LVO detection, speeds intervention and can improve outcomes,” Mayer et al. wrote. “The benefit appears to primarily affect patients presenting within six hours of symptom onset."

Read the entire story in CardiovascularBusiness below:

""

Matt joined Chicago’s TriMed team in 2018 covering all areas of health imaging after two years reporting on the hospital field. He holds a bachelor’s in English from UIC, and enjoys a good cup of coffee and an interesting documentary.

Around the web

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.